EP2211842
AN INHALABLE DRY POWDER FORMULATION COMPRISING GLP-1 FOR USE IN THE TREATMENT OF HYPERGLYCEMIA AND DIABETES BY PULMONARY ADMINISTRATION
:
EP einkaleyfi: Þýðing ekki lögð inn:
24.10.2008:
12.8.2015:
08841194.7
:
23.10.2028
:
AN INHALABLE DRY POWDER FORMULATION COMPRISING GLP-1 FOR USE IN THE TREATMENT OF HYPERGLYCEMIA AND DIABETES BY PULMONARY ADMINISTRATION
24.10.2008
12.8.2015
:
MannKind Corporation:
25134 Rye Canyon Loop, 91355, Valencia CA, US
:
RICHARDSON, Peter:
Ringoes, NJ, US
:
BAUGHMAN, Robert, A.:
Ridgefield, CT, US
:
COSTELLO, Donald:
Bridgewater, NJ, US
:
982368 P:
24.10.2007:
US
:
985620 P:
5.11.2007:
US
:
33740 P:
4.3.2008:
US
:
52127 P:
9.5.2008:
US
:
WO2009055740:
24.10.2008
:
A61K 9/14, A61K 31/495, A61K 38/26, A61P 3/10